Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
E192G
site-directed mutagenesis
E192Q
site-directed mutagenesis
K103A
site-directed mutagenesis
K213A
site-directed mutagenesis
K248A
the mutant shows a reduction in 1D-myo-inositol hexakisphosphate-stimulated ATPase activity of isofom PPIP5K2. The mutant shows a significant reduction in the rate of 1D-myo-inositol phosphate-independent ATPase activity of isofom PPIP5K2
K54A
site-directed mutagenesis
R213A
the mutant shows a reduction in 1D-myo-inositol hexakisphosphate-stimulated ATPase activity of isofom PPIP5K2
R332A
2.4-4fold larger net formation of 1D-myo-inositol 5-diphosphate 1,2,3,4,6-pentakisphosphate, but mutation nearly completely impaires its hydrolysis
R388A
2.4-4fold larger net formation of 1D-myo-inositol 5-diphosphate 1,2,3,4,6-pentakisphosphate, but mutation nearly completely impaires its hydrolysis
R837H
variant R837H segregates with DFNB100-associated hearing loss. Mutation reduces the phosphatase activity of PPIP5K2 and elevates its kinase activity
S347A/S359A
-
no IHPK2 activity
K217A
a kinase-dead mutant IP6K3, the catalytically inactive IP6K3 K217A mutant binds spectrin/adducin similarly to the wild-type enzyme
K226A/S334A
-
catalytically inactive
R133A
-
mutation of IP6K2 in its putative HSP90-binding motif, mutation of Arg133 abolishes IP6K2-HSP90 binding
R136A
-
mutation of IP6K2 in its putative HSP90-binding motif, mutation of Arg136 abolishes IP6K2-HSP90 binding
S118A/S121A
site-directed mutagenesis, no phosphorylation of IP6K1 mutant S118A-S121A in HEK293 cells. The mutant does not efficiently bind Myc-PLIN1 in HEK293 cells
S347A/S359A
-
site-directed mutagenesis, the mutant displays 3.5fold greater TAK1 activation following TNF-alpha, the mutant demonstrates a 6-10fold increase in NF-kappaB DNA binding following TNF-alpha compared with wild type IHPK2-expressing cells in which NF-kappa B DNA binding is inhibited
S85A
site-directed mutagenesis, the mutation does not influence its binding to Myc-PLIN1 in HEK293 cells
W131A
-
mutation of IP6K2 in its putative HSP90-binding motif, mutation of Trp131 modestly diminishes IP6K2-HSP90 binding, the catalytically impaired IP6K2-W131A does not induce cell death
D292A
-
site-directed mutagenesis, inactive mutant
D292A
-
site-directed mutagenesis, inactive mutant
-
additional information
construction of a atipk2alpha/atipk2beta double mutant with male gametophyte and embryogenesis defects, the mutant cannot be rescued by either catalytically inactive or substrate specificity-altered variants of AtIPK2beta. The single knock-out mutant of atipk2alpha is indistinguishable from the wild-type. Transmission analysis of atipk2alpha and atipk2beta mutant alleles and Segregation analysis of atipk2alpha and atipk2beta mutants, overview. Complementation analysis of the atipk2alpha/atipk2beta double mutant, development-defective phenotype
additional information
construction of a atipk2alpha/atipk2beta double mutant with male gametophyte and embryogenesis defects, the mutant cannot be rescued by either catalytically inactive or substrate specificity-altered variants of AtIPK2beta. The single knock-out mutant of atipk2alpha is indistinguishable from the wild-type. Transmission analysis of atipk2alpha and atipk2beta mutant alleles and Segregation analysis of atipk2alpha and atipk2beta mutants, overview. Complementation analysis of the atipk2alpha/atipk2beta double mutant, development-defective phenotype
additional information
construction of a atipk2alpha/atipk2beta double mutant with male gametophyte and embryogenesis defects, the mutant cannot be rescued by either catalytically inactive or substrate specificity-altered variants of AtIPK2beta. The single knock-out mutant of atipk2beta is indistinguishable from the wild-type. Transmission analysis of atipk2alpha and atipk2beta mutant alleles and Segregation analysis of atipk2alpha and atipk2beta mutants, overview. Complementation analysis of the atipk2alpha/atipk2beta double mutant, development-defective phenotype
additional information
construction of a atipk2alpha/atipk2beta double mutant with male gametophyte and embryogenesis defects, the mutant cannot be rescued by either catalytically inactive or substrate specificity-altered variants of AtIPK2beta. The single knock-out mutant of atipk2beta is indistinguishable from the wild-type. Transmission analysis of atipk2alpha and atipk2beta mutant alleles and Segregation analysis of atipk2alpha and atipk2beta mutants, overview. Complementation analysis of the atipk2alpha/atipk2beta double mutant, development-defective phenotype
additional information
construction of an Entamoeba histolytica hybrid IP6K/IP3K chimeric hybrid through molecular modeling and mutagenesis
additional information
-
construction of an Entamoeba histolytica hybrid IP6K/IP3K chimeric hybrid through molecular modeling and mutagenesis
additional information
-
NLS (nuclear localization sequence) mutant of IHPK2 (4 point mutations in the NLS) remains in the cytoplasm, even after interferon-beta treatment
additional information
construction of an N-terminally truncated mutant PPIP5K2KD comprising residues 41-366
additional information
generation of gene Ip6k1 knockout mutant cells
additional information
-
construction of an inactive enzyme mutant, overexpression of wild-type IHPK2 sensitizes ovarian carcinoma cell lines to the growth-suppressive and apoptotic effects of interferon beta, IFN-alpha2, and gamma-irradiation. Expression of a kinase-dead mutant abrogates 50% of the apoptosis induced by IFN-beta
additional information
-
depletion of IP6K2 in HEK-293 cells by RNAi leads to 40-50% reduced cell death, overview. Deletion mapping of IP6K2 to identify HSP90-binding motif, overview. The yeast Saccharomyces cerevisiae possesses constitutive and inducible homologues of HSP90, designated HSC82 and HSP82, respectively. In HSC82 KO yeast, IP6K activity is 2.5fold higher than murine wild-type, in yeast HSP82 null mutant, IP6K catalytic activity is increased but to a lesser extent. Overexpression of HSP90 markedly reduces IP6K catalytic activity in HEK-293 cells
additional information
-
gene deletion of IP6K1 in mice leads to markedly diminished production of inositol diphosphates. Male mutant mice are sterile with defects in spermiogenesis. Mutant mice are smaller than wild-type despite normal food intake. The mutants display markedly lower circulating insulin, phenotype, overview
additional information
construction of IP6K1 knockout MEF cells. Deletion of the Q2 domain results in decreased nuclear localization in more than 60% of cells
additional information
generation of enzyme-deficient Ip6k1-/- mice, phenotype, overview
additional information
generation of gene Ip6k1 knockout mutant cells
additional information
IP6K3 knockdown HEK293 cells are generated by lentiviral transduction. Diminished cerebellar synapses in IP6K3 mutants
additional information
-
generation of gene Ip6k1 knockout mutant cells
-
additional information
-
generation of enzyme-deficient Ip6k1-/- mice, phenotype, overview
-